Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Circulating Cell-free Genome Atlas Study

NCT02889978 is registered in ClinicalTrials.gov with GRAIL, Inc. as lead sponsor.

NCT NCT02889978
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02889978 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Circulating Cell-free Genome Atlas Study
Lead sponsor
GRAIL, Inc.
Phase
Observational
Overall status
Unknown status
Start date
August 4, 2016
Completion date
March 31, 2024
Enrollment
15,254 (actual)
Sites
140

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, neoplasms